Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Synovex Primer** is a Zoetis veterinary growth-promoting ear implant for growing beef steers and heifers. Each two-pellet implant contains **50 mg trenbolone acetate** and **7 mg estradiol benzoate**. Trenbolone acetate provides androgenic anabolic activity, while estradiol benzoate provides estrogenic anabolic activity; together, these steroid hormones alter nutrient partitioning to support lean tissue accretion and increase rate of weight gain. It is administered as a single subcutaneous implant in the middle third of the ear and is approved in the United States for growing beef steers and heifers in a dry lot or on pasture.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Synovex Primer.